Results 31 to 40 of about 11,915,644 (318)

Treatment of Bone Tumors [PDF]

open access: yesSurgical Pathology Clinics, 2012
In this article, the authors summarize the state of the art and future potential in the management of Osteosarcoma, Ewing's sarcoma, and Chondrosarcoma. They cover systemic therapy, surgical therapy, and radiotherapy, along with targeted therapies to inhibit signal transduction pathways.
Rajiv, Rajani, C Parker, Gibbs
openaire   +2 more sources

Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth [PDF]

open access: yes, 2009
Background: Anti-cancer chemotherapy can be simultaneously lymphodepleting and immunostimulatory. Pre-clinical models clearly demonstrate that chemotherapy can synergize with immunotherapy, raising the question how the immune system can be mobilized to ...
Amy Prosser   +51 more
core   +2 more sources

Feasibility of multiomics tumor profiling for guiding treatment of melanoma [PDF]

open access: yes
There is limited evidence supporting the feasibility of using omics and functional technologies to inform treatment decisions. Here we present results from a cohort of 116 melanoma patients in the prospective, multicentric observational Tumor Profiler ...
Frei, Anja   +171 more
core   +1 more source

Angioleiomyoma in the Orbital Apex: A Case Report [PDF]

open access: yes, 2019
A 56-year woman presented eyeball pain and blurred vision. MRI revealed a small well-delineated solid tumor in the apex of right orbit with optic nerve compression.
김세훈   +11 more
core   +1 more source

Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients

open access: yesCancer Cell International, 2019
Background Nectin-4, also known as PVRL4 (poliovirus-receptor-like 4), is specifically expressed in the embryo and placenta. Recent studies have reported that the Nectin-4 is over-expressed in multiple human cancers, and such abnormal expression is ...
Haifeng Deng   +4 more
doaj   +1 more source

TCRP1 activated by mutant p53 promotes NSCLC proliferation via inhibiting FOXO3a

open access: yesOncogenesis, 2022
Previously, our lab explored that tongue cancer resistance-associated protein (TCRP1) plays a central role in cancer chemo-resistance and progression. Absolutely, TCRP1 was significantly increased in lung cancer. But the mechanism is far from elucidated.
Hao Liu   +8 more
doaj   +1 more source

Prognostic value of TIM-1 expression in human non-small-cell lung cancer

open access: yesJournal of Translational Medicine, 2019
Background T-cell immunoglobulin and mucin domain 1 (TIM-1) is an important co-stimulatory molecule which serves as a surface marker for T cell activation, especially for Th2 cells.
Xiao Zheng   +4 more
doaj   +1 more source

The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma

open access: yesCancer Cell International, 2020
Background Hepatocellular carcinoma (HCC) is the most aggressive and frequently diagnosed malignancy of the liver. Despite aggressive therapy, life expectancy of many patients in these cases is extended by only a few months. Hepatocellular carcinoma (HCC)
Yi Xiao   +11 more
doaj   +1 more source

Evaluating IL22RA1 expression as a predictive indicator in human colon cancer progression

open access: yesBMC Cancer
Background Colon cancer is a prevalent malignancy of the digestive tract, consistently ranking among the top three cancers globally in both incidence and mortality.
Xuan Yin   +7 more
doaj   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy